Allakos Raises $32M Series A
December 18, 2012- Share:
San Francisco-based biotech company Allakos has raised a $32 million round of Series A financing led by Novo A/S. The company develops antibody-based therapeutics for the treatment of allergic and inflammatory diseases. With the recent funding, the company is “now well positioned to advance [its] lead program towards meaningful near-term milestones,” according to a press release. Also participating in the round were Alta Partners, RiverVest Venture Partners and the Roche Venture Fund.
- Share:
-
-
-
-